News und Analysen
![Will 2018 Be Johnson & Johnson's Best Year Yet?](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A....
![Will 2018 Be Johnson & Johnson's Best Year Yet?](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A....
![Here's How Acadia Pharmaceuticals Crushed It in 2017](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Here's How Acadia Pharmaceuticals Crushed It in 2017
About 1 million patients in the U.S. suffer from Parkinson's disease. Unfortunately, nearly 40% of them will experience hallucinations and delusions in their daily life, which is a disease state....
![Where Will Organovo Holdings, Inc. Be in 5 Years?](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Where Will Organovo Holdings, Inc. Be in 5 Years?
This has been a year Organovo Holdings Inc. (NASDAQ: ONVO) investors would like to forget. Revenue growth has come to a halt, inciting the market to lop off roughly half of the company's market....
![5 Top Biotech Stocks to Buy Now](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
5 Top Biotech Stocks to Buy Now
Over the last five years, biotech stocks have trounced the performance of the S&P 500. One major reason why is the number of new drugs launched by biotech companies. More diseases than ever....
![The FDA Ushers In a New Era in Cancer Treatment](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
The FDA Ushers In a New Era in Cancer Treatment
On Thursday, Foundation Medicine (NASDAQ: FMI) won a green light for its comprehensive DNA test, FoundationOne CDx. The approval clears the way for healthcare providers to quickly determine what....
![This Marijuana Stock Is Poised for a Breakout Year in 2018 -- Here's What You'll Want to Know About It](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
This Marijuana Stock Is Poised for a Breakout Year in 2018 -- Here's What You'll Want to Know About It
Admittedly, 2017 so far has kind of been a ho-hum year for former high-flying marijuana stock GW Pharmaceuticals (NASDAQ: GWPH). For the most part, investors have just been waiting for the next....
![3 Biotech Stocks to Buy in December](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
3 Biotech Stocks to Buy in December
Black Friday is past. So is Cyber Monday. But it's not too late to buy one of the best Christmas gifts of all -- biotech stocks. Even if your family and friends might prefer other kinds of....
![Better Buy: Pfizer Inc. vs. Johnson & Johnson](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Better Buy: Pfizer Inc. vs. Johnson & Johnson
With only one month remaining in 2017, it's pretty clear which big pharma stock has been the better pick this year between Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). J&J's share....
![Better Buy: Pfizer Inc. vs. Johnson & Johnson](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Better Buy: Pfizer Inc. vs. Johnson & Johnson
With only one month remaining in 2017, it's pretty clear which big pharma stock has been the better pick this year between Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). J&J's share....
![Why Intuitive Surgical Split Its Shares in 2017](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
![Why Intuitive Surgical Split Its Shares in 2017](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
![Why Intuitive Surgical Split Its Shares in 2017](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
![Where Will Novavax, Inc. Be in 5 Years?](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Where Will Novavax, Inc. Be in 5 Years?
Prediction is very difficult, especially if it's about the future.I've always liked that quote from Nobel prize-winning physicist Niels Bohr. And it's 100% correct, of course. But attempting to....
![Why 2017 Was a Year to Remember for Exact Sciences Corporation](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Why 2017 Was a Year to Remember for Exact Sciences Corporation
Any year that a stock goes up 40% would count as a memorable year. But what about a year where a stock soars nearly 340%? That's what has happened for Exact Sciences Corporation (NASDAQ: EXAS) in....
![Here's Why Sangamo Therapeutics Rose as Much as 14.9% Thursday](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Here's Why Sangamo Therapeutics Rose as Much as 14.9% Thursday
Shares of biopharma Sangamo Therapeutics (NASDAQ: SGMO) rose nearly 15% today after the company received favorable coverage in multiple media outlets. Biotech thought leaders STAT Plus and Genetic....
![Gilead Sciences Stock Upgraded: This Is the Power of Free](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
![Gilead Sciences Stock Upgraded: This Is the Power of Free](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
![Gilead Sciences Stock Upgraded: This Is the Power of Free](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
![Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
The American Cancer Society expects 600,920 Americans to die from cancer this year, but Ziopharm Oncology Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) aim to lower that....
![Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
![Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
![Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
![Will Johnson & Johnson Do a Stock Split in 2018?](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and....
![Will Johnson & Johnson Do a Stock Split in 2018?](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and....